04.04.11
Trygg Pharma Holding AS, Oslo, Norway, has appointed Terje Bakken CEO. He previously served as senior vice president, head of supply and trade, with Yara ASA. Mr. Bakken replaces Aaron Kramer, who has been the CEO of Trygg Pharma since its inception, including the transitional period since the establishment of the joint venture between Aker BioMarine and Lindsay Goldberg in November 2010. Mr. Kramer will continue to serve as CEO of the company’s U.S. subsidiary, Trygg Pharma, Inc., as well as the executive vice president of Pharmaceuticals and Business Development of the group.